Global Ifosfamide for Injection Supply, Demand and Key Producers, 2026-2032
The global Ifosfamide for Injection market size is expected to reach $ 312 million by 2032, rising at a market growth of 5.2% CAGR during the forecast period (2026-2032).
Ifosfamide for Injection is a sterile prescription antineoplastic drug product containing ifosfamide for intravenous administration. Commercial presentations include conventional sterile powder, lyophilized powder and, in some markets, ready-to-use solution. The product is supplied in several strengths, most commonly 0.5g, 1g, 2g and 3g per vial.
The report includes branded and generic finished-dose products sold by marketing-authorization holders or manufacturers to hospitals, cancer centers and licensed preparation facilities. All strengths are normalized to one-gram-equivalent vials. Standalone ifosfamide API, research reagents, mesna, combination packs, hospital compounding charges, administration fees and downstream markups are excluded.
The 2025 weighted ASP is US$25 per unit, global sales volume is approximately 8.40 million units, and the estimated average gross margin is approximately 45%.
The upstream chain includes ifosfamide API, pharmaceutical excipients, sterile glass vials, elastomeric closures, seals, labels, cartons and cold-chain or controlled-temperature packaging materials. Midstream activities include cytotoxic sterile formulation, aseptic filling or lyophilization, analytical testing, batch release, packaging, regulatory registration and pharmacovigilance. Downstream channels include pharmaceutical wholesalers, government tenders, hospital pharmacies, cancer centers, centralized intravenous preparation units and licensed emergency-import programs.
Ifosfamide injection is a mature, specialist oncology product rather than a mass-market drug. Demand is supported by established multi-agent regimens, especially in germ-cell tumors and sarcomas, while newer targeted therapies limit very rapid volume growth.
Supply resilience has become a central market issue. Australia and Canada reported shortages or emergency import measures in 2026, illustrating the dependence of several markets on a small number of sterile cytotoxic production lines.
The 1 g vial is the principal global format because it is flexible for hospital preparation. Higher-strength vials reduce handling in high-volume centers, while 0.5 g formats remain useful where smaller dose increments are required.
Pricing is highly regional. Competitive tenders and Indian or Chinese generics keep manufacturer prices low in emerging markets, whereas regulated-market supply, compliance and shortage costs support much higher realized prices in North America and parts of Europe.
Asia-Pacific is expected to grow faster than mature regions as oncology capacity expands and local sterile-injectable manufacturers gain registrations. North America remains important by value, while China and India contribute a larger share of physical volume.
Near-term opportunity lies in reliable supply, additional qualified manufacturing sites, longer shelf life and broader registration coverage. Novel delivery systems should remain outside the base forecast until they obtain approval and commercial sales.
This report is a detailed and comprehensive analysis of the world market for Ifosfamide for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ifosfamide for Injection that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ifosfamide for Injection market
2. What is the demand of the global Ifosfamide for Injection market?
3. What is the year over year growth of the global Ifosfamide for Injection market?
4. What is the total value of the global Ifosfamide for Injection market?
5. Who are the Major Players in the global Ifosfamide for Injection market?
6. What are the growth factors driving the market demand?
Ifosfamide for Injection is a sterile prescription antineoplastic drug product containing ifosfamide for intravenous administration. Commercial presentations include conventional sterile powder, lyophilized powder and, in some markets, ready-to-use solution. The product is supplied in several strengths, most commonly 0.5g, 1g, 2g and 3g per vial.
The report includes branded and generic finished-dose products sold by marketing-authorization holders or manufacturers to hospitals, cancer centers and licensed preparation facilities. All strengths are normalized to one-gram-equivalent vials. Standalone ifosfamide API, research reagents, mesna, combination packs, hospital compounding charges, administration fees and downstream markups are excluded.
The 2025 weighted ASP is US$25 per unit, global sales volume is approximately 8.40 million units, and the estimated average gross margin is approximately 45%.
The upstream chain includes ifosfamide API, pharmaceutical excipients, sterile glass vials, elastomeric closures, seals, labels, cartons and cold-chain or controlled-temperature packaging materials. Midstream activities include cytotoxic sterile formulation, aseptic filling or lyophilization, analytical testing, batch release, packaging, regulatory registration and pharmacovigilance. Downstream channels include pharmaceutical wholesalers, government tenders, hospital pharmacies, cancer centers, centralized intravenous preparation units and licensed emergency-import programs.
Ifosfamide injection is a mature, specialist oncology product rather than a mass-market drug. Demand is supported by established multi-agent regimens, especially in germ-cell tumors and sarcomas, while newer targeted therapies limit very rapid volume growth.
Supply resilience has become a central market issue. Australia and Canada reported shortages or emergency import measures in 2026, illustrating the dependence of several markets on a small number of sterile cytotoxic production lines.
The 1 g vial is the principal global format because it is flexible for hospital preparation. Higher-strength vials reduce handling in high-volume centers, while 0.5 g formats remain useful where smaller dose increments are required.
Pricing is highly regional. Competitive tenders and Indian or Chinese generics keep manufacturer prices low in emerging markets, whereas regulated-market supply, compliance and shortage costs support much higher realized prices in North America and parts of Europe.
Asia-Pacific is expected to grow faster than mature regions as oncology capacity expands and local sterile-injectable manufacturers gain registrations. North America remains important by value, while China and India contribute a larger share of physical volume.
Near-term opportunity lies in reliable supply, additional qualified manufacturing sites, longer shelf life and broader registration coverage. Novel delivery systems should remain outside the base forecast until they obtain approval and commercial sales.
Report Scope
This report studies the global Ifosfamide for Injection production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Ifosfamide for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ifosfamide for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Ifosfamide for Injection total production and demand, 2021-2032, (K Units)
- Global Ifosfamide for Injection total production value, 2021-2032, (USD Million)
- Global Ifosfamide for Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
- Global Ifosfamide for Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
- U.S. VS China: Ifosfamide for Injection domestic production, consumption, key domestic manufacturers and share
- Global Ifosfamide for Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
- Global Ifosfamide for Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
- Global Ifosfamide for Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ifosfamide for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Ifosfamide for Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Ifosfamide for Injection Market, Segmentation by Type:
- Conventional Sterile Powder
- Lyophilized Powder
- Ready-to-Use Solution
Global Ifosfamide for Injection Market, Segmentation by Brand Type:
- Originator or Legacy Brand
- Branded Generic
- Unbranded Generic
Global Ifosfamide for Injection Market, Segmentation by Pack Configuration:
- Single-Vial Pack
- Two-to-Five-Vial Pack
- Six-or-More-Vial Institutional Pack
Global Ifosfamide for Injection Market, Segmentation by Application:
- Hospitals
- Cancer Treatment Centers
- Specialty Clinics
- Other Healthcare Institutions
Companies Profiled:
- Baxter International Inc.
- Fresenius Kabi AG
- Hikma Pharmaceuticals PLC
- Shionogi & Co., Ltd.
- Zydus Lifesciences Limited
- Cipla Limited
- Celon Laboratories Private Limited
- Neon Laboratories Limited
- Aurobindo Pharma Limited (GLS Pharma)
- Getwell Pharma (India) Pvt. Ltd.
- AdvaCare Pharma
- PV Pharma Healthcare Pvt. Ltd.
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Harbin Sanlian Pharmaceutical Co., Ltd.
- Nanjing Pharmaceutical Factory Co., Ltd.
- Sinopharm Group Co., Ltd.
Key Questions Answered
1. How big is the global Ifosfamide for Injection market?2. What is the demand of the global Ifosfamide for Injection market?
3. What is the year over year growth of the global Ifosfamide for Injection market?
4. What is the total value of the global Ifosfamide for Injection market?
5. Who are the Major Players in the global Ifosfamide for Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Ifosfamide for Injection Introduction
1.2 World Ifosfamide for Injection Supply & Forecast
1.2.1 World Ifosfamide for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Ifosfamide for Injection Production (2021-2032)
1.2.3 World Ifosfamide for Injection Pricing Trends (2021-2032)
1.3 World Ifosfamide for Injection Production by Region (Based on Production Site)
1.3.1 World Ifosfamide for Injection Production Value by Region (2021-2032)
1.3.2 World Ifosfamide for Injection Production by Region (2021-2032)
1.3.3 World Ifosfamide for Injection Average Price by Region (2021-2032)
1.3.4 North America Ifosfamide for Injection Production (2021-2032)
1.3.5 Europe Ifosfamide for Injection Production (2021-2032)
1.3.6 China Ifosfamide for Injection Production (2021-2032)
1.3.7 Japan Ifosfamide for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ifosfamide for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ifosfamide for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Ifosfamide for Injection Demand (2021-2032)
2.2 World Ifosfamide for Injection Consumption by Region
2.2.1 World Ifosfamide for Injection Consumption by Region (2021-2026)
2.2.2 World Ifosfamide for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Ifosfamide for Injection Consumption (2021-2032)
2.4 China Ifosfamide for Injection Consumption (2021-2032)
2.5 Europe Ifosfamide for Injection Consumption (2021-2032)
2.6 Japan Ifosfamide for Injection Consumption (2021-2032)
2.7 South Korea Ifosfamide for Injection Consumption (2021-2032)
2.8 ASEAN Ifosfamide for Injection Consumption (2021-2032)
2.9 India Ifosfamide for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ifosfamide for Injection Production Value by Manufacturer (2021-2026)
3.2 World Ifosfamide for Injection Production by Manufacturer (2021-2026)
3.3 World Ifosfamide for Injection Average Price by Manufacturer (2021-2026)
3.4 Ifosfamide for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ifosfamide for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ifosfamide for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Ifosfamide for Injection in 2025
3.6 Ifosfamide for Injection Market: Overall Company Footprint Analysis
3.6.1 Ifosfamide for Injection Market: Region Footprint
3.6.2 Ifosfamide for Injection Market: Company Product Type Footprint
3.6.3 Ifosfamide for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ifosfamide for Injection Production Value Comparison
4.1.1 United States VS China: Ifosfamide for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ifosfamide for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ifosfamide for Injection Production Comparison
4.2.1 United States VS China: Ifosfamide for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ifosfamide for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ifosfamide for Injection Consumption Comparison
4.3.1 United States VS China: Ifosfamide for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ifosfamide for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ifosfamide for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ifosfamide for Injection Production (2021-2026)
4.5 China Based Ifosfamide for Injection Manufacturers and Market Share
4.5.1 China Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Ifosfamide for Injection Production (2021-2026)
4.6 Rest of World Based Ifosfamide for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ifosfamide for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Ifosfamide for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional Sterile Powder
5.2.2 Lyophilized Powder
5.2.3 Ready-to-Use Solution
5.3 Market Segment by Type
5.3.1 World Ifosfamide for Injection Production by Type (2021-2032)
5.3.2 World Ifosfamide for Injection Production Value by Type (2021-2032)
5.3.3 World Ifosfamide for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY BRAND TYPE
6.1 World Ifosfamide for Injection Market Size Overview by Brand Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Brand Type
6.2.1 Originator or Legacy Brand
6.2.2 Branded Generic
6.2.3 Unbranded Generic
6.3 Market Segment by Brand Type
6.3.1 World Ifosfamide for Injection Production by Brand Type (2021-2032)
6.3.2 World Ifosfamide for Injection Production Value by Brand Type (2021-2032)
6.3.3 World Ifosfamide for Injection Average Price by Brand Type (2021-2032)
7 MARKET ANALYSIS BY PACK CONFIGURATION
7.1 World Ifosfamide for Injection Market Size Overview by Pack Configuration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Pack Configuration
7.2.1 Single-Vial Pack
7.2.2 Two-to-Five-Vial Pack
7.2.3 Six-or-More-Vial Institutional Pack
7.3 Market Segment by Pack Configuration
7.3.1 World Ifosfamide for Injection Production by Pack Configuration (2021-2032)
7.3.2 World Ifosfamide for Injection Production Value by Pack Configuration (2021-2032)
7.3.3 World Ifosfamide for Injection Average Price by Pack Configuration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Ifosfamide for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Cancer Treatment Centers
8.2.3 Specialty Clinics
8.2.4 Other Healthcare Institutions
8.3 Market Segment by Application
8.3.1 World Ifosfamide for Injection Production by Application (2021-2032)
8.3.2 World Ifosfamide for Injection Production Value by Application (2021-2032)
8.3.3 World Ifosfamide for Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Baxter International Inc. Details
9.1.2 Baxter International Inc. Major Business
9.1.3 Baxter International Inc. Ifosfamide for Injection Product and Services
9.1.4 Baxter International Inc. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Baxter International Inc. Recent Developments/Updates
9.1.6 Baxter International Inc. Competitive Strengths & Weaknesses
9.2 Fresenius Kabi AG
9.2.1 Fresenius Kabi AG Details
9.2.2 Fresenius Kabi AG Major Business
9.2.3 Fresenius Kabi AG Ifosfamide for Injection Product and Services
9.2.4 Fresenius Kabi AG Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Fresenius Kabi AG Recent Developments/Updates
9.2.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
9.3 Hikma Pharmaceuticals PLC
9.3.1 Hikma Pharmaceuticals PLC Details
9.3.2 Hikma Pharmaceuticals PLC Major Business
9.3.3 Hikma Pharmaceuticals PLC Ifosfamide for Injection Product and Services
9.3.4 Hikma Pharmaceuticals PLC Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
9.3.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
9.4 Shionogi & Co., Ltd.
9.4.1 Shionogi & Co., Ltd. Details
9.4.2 Shionogi & Co., Ltd. Major Business
9.4.3 Shionogi & Co., Ltd. Ifosfamide for Injection Product and Services
9.4.4 Shionogi & Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Shionogi & Co., Ltd. Recent Developments/Updates
9.4.6 Shionogi & Co., Ltd. Competitive Strengths & Weaknesses
9.5 Zydus Lifesciences Limited
9.5.1 Zydus Lifesciences Limited Details
9.5.2 Zydus Lifesciences Limited Major Business
9.5.3 Zydus Lifesciences Limited Ifosfamide for Injection Product and Services
9.5.4 Zydus Lifesciences Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Zydus Lifesciences Limited Recent Developments/Updates
9.5.6 Zydus Lifesciences Limited Competitive Strengths & Weaknesses
9.6 Cipla Limited
9.6.1 Cipla Limited Details
9.6.2 Cipla Limited Major Business
9.6.3 Cipla Limited Ifosfamide for Injection Product and Services
9.6.4 Cipla Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Cipla Limited Recent Developments/Updates
9.6.6 Cipla Limited Competitive Strengths & Weaknesses
9.7 Celon Laboratories Private Limited
9.7.1 Celon Laboratories Private Limited Details
9.7.2 Celon Laboratories Private Limited Major Business
9.7.3 Celon Laboratories Private Limited Ifosfamide for Injection Product and Services
9.7.4 Celon Laboratories Private Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Celon Laboratories Private Limited Recent Developments/Updates
9.7.6 Celon Laboratories Private Limited Competitive Strengths & Weaknesses
9.8 Neon Laboratories Limited
9.8.1 Neon Laboratories Limited Details
9.8.2 Neon Laboratories Limited Major Business
9.8.3 Neon Laboratories Limited Ifosfamide for Injection Product and Services
9.8.4 Neon Laboratories Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Neon Laboratories Limited Recent Developments/Updates
9.8.6 Neon Laboratories Limited Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma Limited (GLS Pharma)
9.9.1 Aurobindo Pharma Limited (GLS Pharma) Details
9.9.2 Aurobindo Pharma Limited (GLS Pharma) Major Business
9.9.3 Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Product and Services
9.9.4 Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Limited (GLS Pharma) Recent Developments/Updates
9.9.6 Aurobindo Pharma Limited (GLS Pharma) Competitive Strengths & Weaknesses
9.10 Getwell Pharma (India) Pvt. Ltd.
9.10.1 Getwell Pharma (India) Pvt. Ltd. Details
9.10.2 Getwell Pharma (India) Pvt. Ltd. Major Business
9.10.3 Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Product and Services
9.10.4 Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Getwell Pharma (India) Pvt. Ltd. Recent Developments/Updates
9.10.6 Getwell Pharma (India) Pvt. Ltd. Competitive Strengths & Weaknesses
9.11 AdvaCare Pharma
9.11.1 AdvaCare Pharma Details
9.11.2 AdvaCare Pharma Major Business
9.11.3 AdvaCare Pharma Ifosfamide for Injection Product and Services
9.11.4 AdvaCare Pharma Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 AdvaCare Pharma Recent Developments/Updates
9.11.6 AdvaCare Pharma Competitive Strengths & Weaknesses
9.12 PV Pharma Healthcare Pvt. Ltd.
9.12.1 PV Pharma Healthcare Pvt. Ltd. Details
9.12.2 PV Pharma Healthcare Pvt. Ltd. Major Business
9.12.3 PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Product and Services
9.12.4 PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 PV Pharma Healthcare Pvt. Ltd. Recent Developments/Updates
9.12.6 PV Pharma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
9.13 Qilu Pharmaceutical (Hainan) Co., Ltd.
9.13.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
9.13.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
9.13.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Product and Services
9.13.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
9.13.6 Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
9.14 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.14.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.14.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.14.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Product and Services
9.14.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.14.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.15 Harbin Sanlian Pharmaceutical Co., Ltd.
9.15.1 Harbin Sanlian Pharmaceutical Co., Ltd. Details
9.15.2 Harbin Sanlian Pharmaceutical Co., Ltd. Major Business
9.15.3 Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Product and Services
9.15.4 Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments/Updates
9.15.6 Harbin Sanlian Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.16 Nanjing Pharmaceutical Factory Co., Ltd.
9.16.1 Nanjing Pharmaceutical Factory Co., Ltd. Details
9.16.2 Nanjing Pharmaceutical Factory Co., Ltd. Major Business
9.16.3 Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Product and Services
9.16.4 Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
9.16.6 Nanjing Pharmaceutical Factory Co., Ltd. Competitive Strengths & Weaknesses
9.17 Sinopharm Group Co., Ltd.
9.17.1 Sinopharm Group Co., Ltd. Details
9.17.2 Sinopharm Group Co., Ltd. Major Business
9.17.3 Sinopharm Group Co., Ltd. Ifosfamide for Injection Product and Services
9.17.4 Sinopharm Group Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Sinopharm Group Co., Ltd. Recent Developments/Updates
9.17.6 Sinopharm Group Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Ifosfamide for Injection Industry Chain
10.2 Ifosfamide for Injection Upstream Analysis
10.2.1 Ifosfamide for Injection Core Raw Materials
10.2.2 Main Manufacturers of Ifosfamide for Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Ifosfamide for Injection Production Mode
10.6 Ifosfamide for Injection Procurement Model
10.7 Ifosfamide for Injection Industry Sales Model and Sales Channels
10.7.1 Ifosfamide for Injection Sales Model
10.7.2 Ifosfamide for Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Ifosfamide for Injection Introduction
1.2 World Ifosfamide for Injection Supply & Forecast
1.2.1 World Ifosfamide for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Ifosfamide for Injection Production (2021-2032)
1.2.3 World Ifosfamide for Injection Pricing Trends (2021-2032)
1.3 World Ifosfamide for Injection Production by Region (Based on Production Site)
1.3.1 World Ifosfamide for Injection Production Value by Region (2021-2032)
1.3.2 World Ifosfamide for Injection Production by Region (2021-2032)
1.3.3 World Ifosfamide for Injection Average Price by Region (2021-2032)
1.3.4 North America Ifosfamide for Injection Production (2021-2032)
1.3.5 Europe Ifosfamide for Injection Production (2021-2032)
1.3.6 China Ifosfamide for Injection Production (2021-2032)
1.3.7 Japan Ifosfamide for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ifosfamide for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ifosfamide for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Ifosfamide for Injection Demand (2021-2032)
2.2 World Ifosfamide for Injection Consumption by Region
2.2.1 World Ifosfamide for Injection Consumption by Region (2021-2026)
2.2.2 World Ifosfamide for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Ifosfamide for Injection Consumption (2021-2032)
2.4 China Ifosfamide for Injection Consumption (2021-2032)
2.5 Europe Ifosfamide for Injection Consumption (2021-2032)
2.6 Japan Ifosfamide for Injection Consumption (2021-2032)
2.7 South Korea Ifosfamide for Injection Consumption (2021-2032)
2.8 ASEAN Ifosfamide for Injection Consumption (2021-2032)
2.9 India Ifosfamide for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ifosfamide for Injection Production Value by Manufacturer (2021-2026)
3.2 World Ifosfamide for Injection Production by Manufacturer (2021-2026)
3.3 World Ifosfamide for Injection Average Price by Manufacturer (2021-2026)
3.4 Ifosfamide for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ifosfamide for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ifosfamide for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Ifosfamide for Injection in 2025
3.6 Ifosfamide for Injection Market: Overall Company Footprint Analysis
3.6.1 Ifosfamide for Injection Market: Region Footprint
3.6.2 Ifosfamide for Injection Market: Company Product Type Footprint
3.6.3 Ifosfamide for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ifosfamide for Injection Production Value Comparison
4.1.1 United States VS China: Ifosfamide for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Ifosfamide for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Ifosfamide for Injection Production Comparison
4.2.1 United States VS China: Ifosfamide for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Ifosfamide for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Ifosfamide for Injection Consumption Comparison
4.3.1 United States VS China: Ifosfamide for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Ifosfamide for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Ifosfamide for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Ifosfamide for Injection Production (2021-2026)
4.5 China Based Ifosfamide for Injection Manufacturers and Market Share
4.5.1 China Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Ifosfamide for Injection Production (2021-2026)
4.6 Rest of World Based Ifosfamide for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ifosfamide for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Ifosfamide for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Ifosfamide for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Conventional Sterile Powder
5.2.2 Lyophilized Powder
5.2.3 Ready-to-Use Solution
5.3 Market Segment by Type
5.3.1 World Ifosfamide for Injection Production by Type (2021-2032)
5.3.2 World Ifosfamide for Injection Production Value by Type (2021-2032)
5.3.3 World Ifosfamide for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY BRAND TYPE
6.1 World Ifosfamide for Injection Market Size Overview by Brand Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Brand Type
6.2.1 Originator or Legacy Brand
6.2.2 Branded Generic
6.2.3 Unbranded Generic
6.3 Market Segment by Brand Type
6.3.1 World Ifosfamide for Injection Production by Brand Type (2021-2032)
6.3.2 World Ifosfamide for Injection Production Value by Brand Type (2021-2032)
6.3.3 World Ifosfamide for Injection Average Price by Brand Type (2021-2032)
7 MARKET ANALYSIS BY PACK CONFIGURATION
7.1 World Ifosfamide for Injection Market Size Overview by Pack Configuration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Pack Configuration
7.2.1 Single-Vial Pack
7.2.2 Two-to-Five-Vial Pack
7.2.3 Six-or-More-Vial Institutional Pack
7.3 Market Segment by Pack Configuration
7.3.1 World Ifosfamide for Injection Production by Pack Configuration (2021-2032)
7.3.2 World Ifosfamide for Injection Production Value by Pack Configuration (2021-2032)
7.3.3 World Ifosfamide for Injection Average Price by Pack Configuration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Ifosfamide for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Cancer Treatment Centers
8.2.3 Specialty Clinics
8.2.4 Other Healthcare Institutions
8.3 Market Segment by Application
8.3.1 World Ifosfamide for Injection Production by Application (2021-2032)
8.3.2 World Ifosfamide for Injection Production Value by Application (2021-2032)
8.3.3 World Ifosfamide for Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Baxter International Inc.
9.1.1 Baxter International Inc. Details
9.1.2 Baxter International Inc. Major Business
9.1.3 Baxter International Inc. Ifosfamide for Injection Product and Services
9.1.4 Baxter International Inc. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Baxter International Inc. Recent Developments/Updates
9.1.6 Baxter International Inc. Competitive Strengths & Weaknesses
9.2 Fresenius Kabi AG
9.2.1 Fresenius Kabi AG Details
9.2.2 Fresenius Kabi AG Major Business
9.2.3 Fresenius Kabi AG Ifosfamide for Injection Product and Services
9.2.4 Fresenius Kabi AG Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Fresenius Kabi AG Recent Developments/Updates
9.2.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
9.3 Hikma Pharmaceuticals PLC
9.3.1 Hikma Pharmaceuticals PLC Details
9.3.2 Hikma Pharmaceuticals PLC Major Business
9.3.3 Hikma Pharmaceuticals PLC Ifosfamide for Injection Product and Services
9.3.4 Hikma Pharmaceuticals PLC Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
9.3.6 Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
9.4 Shionogi & Co., Ltd.
9.4.1 Shionogi & Co., Ltd. Details
9.4.2 Shionogi & Co., Ltd. Major Business
9.4.3 Shionogi & Co., Ltd. Ifosfamide for Injection Product and Services
9.4.4 Shionogi & Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Shionogi & Co., Ltd. Recent Developments/Updates
9.4.6 Shionogi & Co., Ltd. Competitive Strengths & Weaknesses
9.5 Zydus Lifesciences Limited
9.5.1 Zydus Lifesciences Limited Details
9.5.2 Zydus Lifesciences Limited Major Business
9.5.3 Zydus Lifesciences Limited Ifosfamide for Injection Product and Services
9.5.4 Zydus Lifesciences Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Zydus Lifesciences Limited Recent Developments/Updates
9.5.6 Zydus Lifesciences Limited Competitive Strengths & Weaknesses
9.6 Cipla Limited
9.6.1 Cipla Limited Details
9.6.2 Cipla Limited Major Business
9.6.3 Cipla Limited Ifosfamide for Injection Product and Services
9.6.4 Cipla Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Cipla Limited Recent Developments/Updates
9.6.6 Cipla Limited Competitive Strengths & Weaknesses
9.7 Celon Laboratories Private Limited
9.7.1 Celon Laboratories Private Limited Details
9.7.2 Celon Laboratories Private Limited Major Business
9.7.3 Celon Laboratories Private Limited Ifosfamide for Injection Product and Services
9.7.4 Celon Laboratories Private Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Celon Laboratories Private Limited Recent Developments/Updates
9.7.6 Celon Laboratories Private Limited Competitive Strengths & Weaknesses
9.8 Neon Laboratories Limited
9.8.1 Neon Laboratories Limited Details
9.8.2 Neon Laboratories Limited Major Business
9.8.3 Neon Laboratories Limited Ifosfamide for Injection Product and Services
9.8.4 Neon Laboratories Limited Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Neon Laboratories Limited Recent Developments/Updates
9.8.6 Neon Laboratories Limited Competitive Strengths & Weaknesses
9.9 Aurobindo Pharma Limited (GLS Pharma)
9.9.1 Aurobindo Pharma Limited (GLS Pharma) Details
9.9.2 Aurobindo Pharma Limited (GLS Pharma) Major Business
9.9.3 Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Product and Services
9.9.4 Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Aurobindo Pharma Limited (GLS Pharma) Recent Developments/Updates
9.9.6 Aurobindo Pharma Limited (GLS Pharma) Competitive Strengths & Weaknesses
9.10 Getwell Pharma (India) Pvt. Ltd.
9.10.1 Getwell Pharma (India) Pvt. Ltd. Details
9.10.2 Getwell Pharma (India) Pvt. Ltd. Major Business
9.10.3 Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Product and Services
9.10.4 Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Getwell Pharma (India) Pvt. Ltd. Recent Developments/Updates
9.10.6 Getwell Pharma (India) Pvt. Ltd. Competitive Strengths & Weaknesses
9.11 AdvaCare Pharma
9.11.1 AdvaCare Pharma Details
9.11.2 AdvaCare Pharma Major Business
9.11.3 AdvaCare Pharma Ifosfamide for Injection Product and Services
9.11.4 AdvaCare Pharma Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 AdvaCare Pharma Recent Developments/Updates
9.11.6 AdvaCare Pharma Competitive Strengths & Weaknesses
9.12 PV Pharma Healthcare Pvt. Ltd.
9.12.1 PV Pharma Healthcare Pvt. Ltd. Details
9.12.2 PV Pharma Healthcare Pvt. Ltd. Major Business
9.12.3 PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Product and Services
9.12.4 PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 PV Pharma Healthcare Pvt. Ltd. Recent Developments/Updates
9.12.6 PV Pharma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
9.13 Qilu Pharmaceutical (Hainan) Co., Ltd.
9.13.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
9.13.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
9.13.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Product and Services
9.13.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
9.13.6 Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
9.14 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
9.14.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
9.14.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
9.14.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Product and Services
9.14.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
9.14.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
9.15 Harbin Sanlian Pharmaceutical Co., Ltd.
9.15.1 Harbin Sanlian Pharmaceutical Co., Ltd. Details
9.15.2 Harbin Sanlian Pharmaceutical Co., Ltd. Major Business
9.15.3 Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Product and Services
9.15.4 Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments/Updates
9.15.6 Harbin Sanlian Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.16 Nanjing Pharmaceutical Factory Co., Ltd.
9.16.1 Nanjing Pharmaceutical Factory Co., Ltd. Details
9.16.2 Nanjing Pharmaceutical Factory Co., Ltd. Major Business
9.16.3 Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Product and Services
9.16.4 Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
9.16.6 Nanjing Pharmaceutical Factory Co., Ltd. Competitive Strengths & Weaknesses
9.17 Sinopharm Group Co., Ltd.
9.17.1 Sinopharm Group Co., Ltd. Details
9.17.2 Sinopharm Group Co., Ltd. Major Business
9.17.3 Sinopharm Group Co., Ltd. Ifosfamide for Injection Product and Services
9.17.4 Sinopharm Group Co., Ltd. Ifosfamide for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Sinopharm Group Co., Ltd. Recent Developments/Updates
9.17.6 Sinopharm Group Co., Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Ifosfamide for Injection Industry Chain
10.2 Ifosfamide for Injection Upstream Analysis
10.2.1 Ifosfamide for Injection Core Raw Materials
10.2.2 Main Manufacturers of Ifosfamide for Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Ifosfamide for Injection Production Mode
10.6 Ifosfamide for Injection Procurement Model
10.7 Ifosfamide for Injection Industry Sales Model and Sales Channels
10.7.1 Ifosfamide for Injection Sales Model
10.7.2 Ifosfamide for Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Ifosfamide for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ifosfamide for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ifosfamide for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ifosfamide for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Ifosfamide for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Ifosfamide for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Ifosfamide for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Ifosfamide for Injection Production Market Share by Region (2021-2026)
Table 9. World Ifosfamide for Injection Production Market Share by Region (2027-2032)
Table 10. World Ifosfamide for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ifosfamide for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ifosfamide for Injection Major Market Trends
Table 13. World Ifosfamide for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ifosfamide for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Ifosfamide for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ifosfamide for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ifosfamide for Injection Producers in 2025
Table 18. World Ifosfamide for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ifosfamide for Injection Producers in 2025
Table 20. World Ifosfamide for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ifosfamide for Injection Company Evaluation Quadrant
Table 22. World Ifosfamide for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ifosfamide for Injection Production Site of Key Manufacturer
Table 24. Ifosfamide for Injection Market: Company Product Type Footprint
Table 25. Ifosfamide for Injection Market: Company Product Application Footprint
Table 26. Ifosfamide for Injection Competitive Factors
Table 27. Ifosfamide for Injection New Entrant and Capacity Expansion Plans
Table 28. Ifosfamide for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Ifosfamide for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ifosfamide for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ifosfamide for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ifosfamide for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 37. China Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ifosfamide for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ifosfamide for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 47. World Ifosfamide for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Ifosfamide for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Ifosfamide for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Ifosfamide for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Ifosfamide for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Ifosfamide for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Ifosfamide for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Ifosfamide for Injection Production Value by Brand Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Ifosfamide for Injection Production by Brand Type (2021-2026) & (K Units)
Table 56. World Ifosfamide for Injection Production by Brand Type (2027-2032) & (K Units)
Table 57. World Ifosfamide for Injection Production Value by Brand Type (2021-2026) & (USD Million)
Table 58. World Ifosfamide for Injection Production Value by Brand Type (2027-2032) & (USD Million)
Table 59. World Ifosfamide for Injection Average Price by Brand Type (2021-2026) & (US$/Unit)
Table 60. World Ifosfamide for Injection Average Price by Brand Type (2027-2032) & (US$/Unit)
Table 61. World Ifosfamide for Injection Production Value by Pack Configuration, (USD Million), 2021 & 2025 & 2032
Table 62. World Ifosfamide for Injection Production by Pack Configuration (2021-2026) & (K Units)
Table 63. World Ifosfamide for Injection Production by Pack Configuration (2027-2032) & (K Units)
Table 64. World Ifosfamide for Injection Production Value by Pack Configuration (2021-2026) & (USD Million)
Table 65. World Ifosfamide for Injection Production Value by Pack Configuration (2027-2032) & (USD Million)
Table 66. World Ifosfamide for Injection Average Price by Pack Configuration (2021-2026) & (US$/Unit)
Table 67. World Ifosfamide for Injection Average Price by Pack Configuration (2027-2032) & (US$/Unit)
Table 68. World Ifosfamide for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Ifosfamide for Injection Production by Application (2021-2026) & (K Units)
Table 70. World Ifosfamide for Injection Production by Application (2027-2032) & (K Units)
Table 71. World Ifosfamide for Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Ifosfamide for Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Ifosfamide for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Ifosfamide for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Baxter International Inc. Major Business
Table 77. Baxter International Inc. Ifosfamide for Injection Product and Services
Table 78. Baxter International Inc. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Baxter International Inc. Recent Developments/Updates
Table 80. Baxter International Inc. Competitive Strengths & Weaknesses
Table 81. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 82. Fresenius Kabi AG Major Business
Table 83. Fresenius Kabi AG Ifosfamide for Injection Product and Services
Table 84. Fresenius Kabi AG Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Fresenius Kabi AG Recent Developments/Updates
Table 86. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 87. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 88. Hikma Pharmaceuticals PLC Major Business
Table 89. Hikma Pharmaceuticals PLC Ifosfamide for Injection Product and Services
Table 90. Hikma Pharmaceuticals PLC Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 92. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 93. Shionogi & Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 94. Shionogi & Co., Ltd. Major Business
Table 95. Shionogi & Co., Ltd. Ifosfamide for Injection Product and Services
Table 96. Shionogi & Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Shionogi & Co., Ltd. Recent Developments/Updates
Table 98. Shionogi & Co., Ltd. Competitive Strengths & Weaknesses
Table 99. Zydus Lifesciences Limited Basic Information, Manufacturing Base and Competitors
Table 100. Zydus Lifesciences Limited Major Business
Table 101. Zydus Lifesciences Limited Ifosfamide for Injection Product and Services
Table 102. Zydus Lifesciences Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Zydus Lifesciences Limited Recent Developments/Updates
Table 104. Zydus Lifesciences Limited Competitive Strengths & Weaknesses
Table 105. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 106. Cipla Limited Major Business
Table 107. Cipla Limited Ifosfamide for Injection Product and Services
Table 108. Cipla Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Cipla Limited Recent Developments/Updates
Table 110. Cipla Limited Competitive Strengths & Weaknesses
Table 111. Celon Laboratories Private Limited Basic Information, Manufacturing Base and Competitors
Table 112. Celon Laboratories Private Limited Major Business
Table 113. Celon Laboratories Private Limited Ifosfamide for Injection Product and Services
Table 114. Celon Laboratories Private Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Celon Laboratories Private Limited Recent Developments/Updates
Table 116. Celon Laboratories Private Limited Competitive Strengths & Weaknesses
Table 117. Neon Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 118. Neon Laboratories Limited Major Business
Table 119. Neon Laboratories Limited Ifosfamide for Injection Product and Services
Table 120. Neon Laboratories Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Neon Laboratories Limited Recent Developments/Updates
Table 122. Neon Laboratories Limited Competitive Strengths & Weaknesses
Table 123. Aurobindo Pharma Limited (GLS Pharma) Basic Information, Manufacturing Base and Competitors
Table 124. Aurobindo Pharma Limited (GLS Pharma) Major Business
Table 125. Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Product and Services
Table 126. Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Aurobindo Pharma Limited (GLS Pharma) Recent Developments/Updates
Table 128. Aurobindo Pharma Limited (GLS Pharma) Competitive Strengths & Weaknesses
Table 129. Getwell Pharma (India) Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Getwell Pharma (India) Pvt. Ltd. Major Business
Table 131. Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Product and Services
Table 132. Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Getwell Pharma (India) Pvt. Ltd. Recent Developments/Updates
Table 134. Getwell Pharma (India) Pvt. Ltd. Competitive Strengths & Weaknesses
Table 135. AdvaCare Pharma Basic Information, Manufacturing Base and Competitors
Table 136. AdvaCare Pharma Major Business
Table 137. AdvaCare Pharma Ifosfamide for Injection Product and Services
Table 138. AdvaCare Pharma Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. AdvaCare Pharma Recent Developments/Updates
Table 140. AdvaCare Pharma Competitive Strengths & Weaknesses
Table 141. PV Pharma Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 142. PV Pharma Healthcare Pvt. Ltd. Major Business
Table 143. PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Product and Services
Table 144. PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. PV Pharma Healthcare Pvt. Ltd. Recent Developments/Updates
Table 146. PV Pharma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 147. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Product and Services
Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
Table 152. Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 155. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Product and Services
Table 156. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 158. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Harbin Sanlian Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Harbin Sanlian Pharmaceutical Co., Ltd. Major Business
Table 161. Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Product and Services
Table 162. Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 164. Harbin Sanlian Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Nanjing Pharmaceutical Factory Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Nanjing Pharmaceutical Factory Co., Ltd. Major Business
Table 167. Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Product and Services
Table 168. Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 170. Nanjing Pharmaceutical Factory Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Sinopharm Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Sinopharm Group Co., Ltd. Major Business
Table 173. Sinopharm Group Co., Ltd. Ifosfamide for Injection Product and Services
Table 174. Sinopharm Group Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Sinopharm Group Co., Ltd. Recent Developments/Updates
Table 176. Sinopharm Group Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Global Key Players of Ifosfamide for Injection Upstream (Raw Materials)
Table 178. Global Ifosfamide for Injection Typical Customers
Table 179. Ifosfamide for Injection Typical Distributors
Table 1. World Ifosfamide for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Ifosfamide for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Ifosfamide for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Ifosfamide for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Ifosfamide for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Ifosfamide for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Ifosfamide for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Ifosfamide for Injection Production Market Share by Region (2021-2026)
Table 9. World Ifosfamide for Injection Production Market Share by Region (2027-2032)
Table 10. World Ifosfamide for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Ifosfamide for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Ifosfamide for Injection Major Market Trends
Table 13. World Ifosfamide for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Ifosfamide for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Ifosfamide for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Ifosfamide for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Ifosfamide for Injection Producers in 2025
Table 18. World Ifosfamide for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Ifosfamide for Injection Producers in 2025
Table 20. World Ifosfamide for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Ifosfamide for Injection Company Evaluation Quadrant
Table 22. World Ifosfamide for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Ifosfamide for Injection Production Site of Key Manufacturer
Table 24. Ifosfamide for Injection Market: Company Product Type Footprint
Table 25. Ifosfamide for Injection Market: Company Product Application Footprint
Table 26. Ifosfamide for Injection Competitive Factors
Table 27. Ifosfamide for Injection New Entrant and Capacity Expansion Plans
Table 28. Ifosfamide for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Ifosfamide for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Ifosfamide for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Ifosfamide for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Ifosfamide for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 37. China Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Ifosfamide for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Ifosfamide for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Ifosfamide for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Ifosfamide for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Ifosfamide for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Ifosfamide for Injection Production Market Share (2021-2026)
Table 47. World Ifosfamide for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Ifosfamide for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Ifosfamide for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Ifosfamide for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Ifosfamide for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Ifosfamide for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Ifosfamide for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Ifosfamide for Injection Production Value by Brand Type, (USD Million), 2021 & 2025 & 2032
Table 55. World Ifosfamide for Injection Production by Brand Type (2021-2026) & (K Units)
Table 56. World Ifosfamide for Injection Production by Brand Type (2027-2032) & (K Units)
Table 57. World Ifosfamide for Injection Production Value by Brand Type (2021-2026) & (USD Million)
Table 58. World Ifosfamide for Injection Production Value by Brand Type (2027-2032) & (USD Million)
Table 59. World Ifosfamide for Injection Average Price by Brand Type (2021-2026) & (US$/Unit)
Table 60. World Ifosfamide for Injection Average Price by Brand Type (2027-2032) & (US$/Unit)
Table 61. World Ifosfamide for Injection Production Value by Pack Configuration, (USD Million), 2021 & 2025 & 2032
Table 62. World Ifosfamide for Injection Production by Pack Configuration (2021-2026) & (K Units)
Table 63. World Ifosfamide for Injection Production by Pack Configuration (2027-2032) & (K Units)
Table 64. World Ifosfamide for Injection Production Value by Pack Configuration (2021-2026) & (USD Million)
Table 65. World Ifosfamide for Injection Production Value by Pack Configuration (2027-2032) & (USD Million)
Table 66. World Ifosfamide for Injection Average Price by Pack Configuration (2021-2026) & (US$/Unit)
Table 67. World Ifosfamide for Injection Average Price by Pack Configuration (2027-2032) & (US$/Unit)
Table 68. World Ifosfamide for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Ifosfamide for Injection Production by Application (2021-2026) & (K Units)
Table 70. World Ifosfamide for Injection Production by Application (2027-2032) & (K Units)
Table 71. World Ifosfamide for Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Ifosfamide for Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Ifosfamide for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Ifosfamide for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Baxter International Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Baxter International Inc. Major Business
Table 77. Baxter International Inc. Ifosfamide for Injection Product and Services
Table 78. Baxter International Inc. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Baxter International Inc. Recent Developments/Updates
Table 80. Baxter International Inc. Competitive Strengths & Weaknesses
Table 81. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 82. Fresenius Kabi AG Major Business
Table 83. Fresenius Kabi AG Ifosfamide for Injection Product and Services
Table 84. Fresenius Kabi AG Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Fresenius Kabi AG Recent Developments/Updates
Table 86. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 87. Hikma Pharmaceuticals PLC Basic Information, Manufacturing Base and Competitors
Table 88. Hikma Pharmaceuticals PLC Major Business
Table 89. Hikma Pharmaceuticals PLC Ifosfamide for Injection Product and Services
Table 90. Hikma Pharmaceuticals PLC Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 92. Hikma Pharmaceuticals PLC Competitive Strengths & Weaknesses
Table 93. Shionogi & Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 94. Shionogi & Co., Ltd. Major Business
Table 95. Shionogi & Co., Ltd. Ifosfamide for Injection Product and Services
Table 96. Shionogi & Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Shionogi & Co., Ltd. Recent Developments/Updates
Table 98. Shionogi & Co., Ltd. Competitive Strengths & Weaknesses
Table 99. Zydus Lifesciences Limited Basic Information, Manufacturing Base and Competitors
Table 100. Zydus Lifesciences Limited Major Business
Table 101. Zydus Lifesciences Limited Ifosfamide for Injection Product and Services
Table 102. Zydus Lifesciences Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Zydus Lifesciences Limited Recent Developments/Updates
Table 104. Zydus Lifesciences Limited Competitive Strengths & Weaknesses
Table 105. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 106. Cipla Limited Major Business
Table 107. Cipla Limited Ifosfamide for Injection Product and Services
Table 108. Cipla Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Cipla Limited Recent Developments/Updates
Table 110. Cipla Limited Competitive Strengths & Weaknesses
Table 111. Celon Laboratories Private Limited Basic Information, Manufacturing Base and Competitors
Table 112. Celon Laboratories Private Limited Major Business
Table 113. Celon Laboratories Private Limited Ifosfamide for Injection Product and Services
Table 114. Celon Laboratories Private Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Celon Laboratories Private Limited Recent Developments/Updates
Table 116. Celon Laboratories Private Limited Competitive Strengths & Weaknesses
Table 117. Neon Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 118. Neon Laboratories Limited Major Business
Table 119. Neon Laboratories Limited Ifosfamide for Injection Product and Services
Table 120. Neon Laboratories Limited Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Neon Laboratories Limited Recent Developments/Updates
Table 122. Neon Laboratories Limited Competitive Strengths & Weaknesses
Table 123. Aurobindo Pharma Limited (GLS Pharma) Basic Information, Manufacturing Base and Competitors
Table 124. Aurobindo Pharma Limited (GLS Pharma) Major Business
Table 125. Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Product and Services
Table 126. Aurobindo Pharma Limited (GLS Pharma) Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Aurobindo Pharma Limited (GLS Pharma) Recent Developments/Updates
Table 128. Aurobindo Pharma Limited (GLS Pharma) Competitive Strengths & Weaknesses
Table 129. Getwell Pharma (India) Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Getwell Pharma (India) Pvt. Ltd. Major Business
Table 131. Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Product and Services
Table 132. Getwell Pharma (India) Pvt. Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Getwell Pharma (India) Pvt. Ltd. Recent Developments/Updates
Table 134. Getwell Pharma (India) Pvt. Ltd. Competitive Strengths & Weaknesses
Table 135. AdvaCare Pharma Basic Information, Manufacturing Base and Competitors
Table 136. AdvaCare Pharma Major Business
Table 137. AdvaCare Pharma Ifosfamide for Injection Product and Services
Table 138. AdvaCare Pharma Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. AdvaCare Pharma Recent Developments/Updates
Table 140. AdvaCare Pharma Competitive Strengths & Weaknesses
Table 141. PV Pharma Healthcare Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 142. PV Pharma Healthcare Pvt. Ltd. Major Business
Table 143. PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Product and Services
Table 144. PV Pharma Healthcare Pvt. Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. PV Pharma Healthcare Pvt. Ltd. Recent Developments/Updates
Table 146. PV Pharma Healthcare Pvt. Ltd. Competitive Strengths & Weaknesses
Table 147. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Product and Services
Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
Table 152. Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
Table 153. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 154. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
Table 155. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Product and Services
Table 156. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 158. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 159. Harbin Sanlian Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 160. Harbin Sanlian Pharmaceutical Co., Ltd. Major Business
Table 161. Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Product and Services
Table 162. Harbin Sanlian Pharmaceutical Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Harbin Sanlian Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 164. Harbin Sanlian Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 165. Nanjing Pharmaceutical Factory Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Nanjing Pharmaceutical Factory Co., Ltd. Major Business
Table 167. Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Product and Services
Table 168. Nanjing Pharmaceutical Factory Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 170. Nanjing Pharmaceutical Factory Co., Ltd. Competitive Strengths & Weaknesses
Table 171. Sinopharm Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 172. Sinopharm Group Co., Ltd. Major Business
Table 173. Sinopharm Group Co., Ltd. Ifosfamide for Injection Product and Services
Table 174. Sinopharm Group Co., Ltd. Ifosfamide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Sinopharm Group Co., Ltd. Recent Developments/Updates
Table 176. Sinopharm Group Co., Ltd. Competitive Strengths & Weaknesses
Table 177. Global Key Players of Ifosfamide for Injection Upstream (Raw Materials)
Table 178. Global Ifosfamide for Injection Typical Customers
Table 179. Ifosfamide for Injection Typical Distributors
LIST OF FIGURES
Figure 1. Ifosfamide for Injection Picture
Figure 2. World Ifosfamide for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ifosfamide for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 5. World Ifosfamide for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ifosfamide for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Ifosfamide for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 10. China Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 12. Ifosfamide for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 15. World Ifosfamide for Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 17. China Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 22. India Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Ifosfamide for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ifosfamide for Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ifosfamide for Injection Markets in 2025
Figure 26. United States VS China: Ifosfamide for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Ifosfamide for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ifosfamide for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 30. China Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 32. World Ifosfamide for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Ifosfamide for Injection Production Value Market Share by Type in 2025
Figure 34. Conventional Sterile Powder
Figure 35. Lyophilized Powder
Figure 36. Ready-to-Use Solution
Figure 37. World Ifosfamide for Injection Production Market Share by Type (2021-2032)
Figure 38. World Ifosfamide for Injection Production Value Market Share by Type (2021-2032)
Figure 39. World Ifosfamide for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Ifosfamide for Injection Production Value by Brand Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Ifosfamide for Injection Production Value Market Share by Brand Type in 2025
Figure 42. Originator or Legacy Brand
Figure 43. Branded Generic
Figure 44. Unbranded Generic
Figure 45. World Ifosfamide for Injection Production Market Share by Brand Type (2021-2032)
Figure 46. World Ifosfamide for Injection Production Value Market Share by Brand Type (2021-2032)
Figure 47. World Ifosfamide for Injection Average Price by Brand Type (2021-2032) & (US$/Unit)
Figure 48. World Ifosfamide for Injection Production Value by Pack Configuration, (USD Million), 2021 & 2025 & 2032
Figure 49. World Ifosfamide for Injection Production Value Market Share by Pack Configuration in 2025
Figure 50. Single-Vial Pack
Figure 51. Two-to-Five-Vial Pack
Figure 52. Six-or-More-Vial Institutional Pack
Figure 53. World Ifosfamide for Injection Production Market Share by Pack Configuration (2021-2032)
Figure 54. World Ifosfamide for Injection Production Value Market Share by Pack Configuration (2021-2032)
Figure 55. World Ifosfamide for Injection Average Price by Pack Configuration (2021-2032) & (US$/Unit)
Figure 56. World Ifosfamide for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Ifosfamide for Injection Production Value Market Share by Application in 2025
Figure 58. Hospitals
Figure 59. Cancer Treatment Centers
Figure 60. Specialty Clinics
Figure 61. Other Healthcare Institutions
Figure 62. World Ifosfamide for Injection Production Market Share by Application (2021-2032)
Figure 63. World Ifosfamide for Injection Production Value Market Share by Application (2021-2032)
Figure 64. World Ifosfamide for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 65. Ifosfamide for Injection Industry Chain
Figure 66. Ifosfamide for Injection Procurement Model
Figure 67. Ifosfamide for Injection Sales Model
Figure 68. Ifosfamide for Injection Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Ifosfamide for Injection Picture
Figure 2. World Ifosfamide for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Ifosfamide for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 5. World Ifosfamide for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Ifosfamide for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Ifosfamide for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 10. China Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Ifosfamide for Injection Production (2021-2032) & (K Units)
Figure 12. Ifosfamide for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 15. World Ifosfamide for Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 17. China Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 22. India Ifosfamide for Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Ifosfamide for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ifosfamide for Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ifosfamide for Injection Markets in 2025
Figure 26. United States VS China: Ifosfamide for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Ifosfamide for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Ifosfamide for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 30. China Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Ifosfamide for Injection Production Market Share 2025
Figure 32. World Ifosfamide for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Ifosfamide for Injection Production Value Market Share by Type in 2025
Figure 34. Conventional Sterile Powder
Figure 35. Lyophilized Powder
Figure 36. Ready-to-Use Solution
Figure 37. World Ifosfamide for Injection Production Market Share by Type (2021-2032)
Figure 38. World Ifosfamide for Injection Production Value Market Share by Type (2021-2032)
Figure 39. World Ifosfamide for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Ifosfamide for Injection Production Value by Brand Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Ifosfamide for Injection Production Value Market Share by Brand Type in 2025
Figure 42. Originator or Legacy Brand
Figure 43. Branded Generic
Figure 44. Unbranded Generic
Figure 45. World Ifosfamide for Injection Production Market Share by Brand Type (2021-2032)
Figure 46. World Ifosfamide for Injection Production Value Market Share by Brand Type (2021-2032)
Figure 47. World Ifosfamide for Injection Average Price by Brand Type (2021-2032) & (US$/Unit)
Figure 48. World Ifosfamide for Injection Production Value by Pack Configuration, (USD Million), 2021 & 2025 & 2032
Figure 49. World Ifosfamide for Injection Production Value Market Share by Pack Configuration in 2025
Figure 50. Single-Vial Pack
Figure 51. Two-to-Five-Vial Pack
Figure 52. Six-or-More-Vial Institutional Pack
Figure 53. World Ifosfamide for Injection Production Market Share by Pack Configuration (2021-2032)
Figure 54. World Ifosfamide for Injection Production Value Market Share by Pack Configuration (2021-2032)
Figure 55. World Ifosfamide for Injection Average Price by Pack Configuration (2021-2032) & (US$/Unit)
Figure 56. World Ifosfamide for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World Ifosfamide for Injection Production Value Market Share by Application in 2025
Figure 58. Hospitals
Figure 59. Cancer Treatment Centers
Figure 60. Specialty Clinics
Figure 61. Other Healthcare Institutions
Figure 62. World Ifosfamide for Injection Production Market Share by Application (2021-2032)
Figure 63. World Ifosfamide for Injection Production Value Market Share by Application (2021-2032)
Figure 64. World Ifosfamide for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 65. Ifosfamide for Injection Industry Chain
Figure 66. Ifosfamide for Injection Procurement Model
Figure 67. Ifosfamide for Injection Sales Model
Figure 68. Ifosfamide for Injection Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
